PL354991A1 - Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist - Google Patents

Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist

Info

Publication number
PL354991A1
PL354991A1 PL00354991A PL35499100A PL354991A1 PL 354991 A1 PL354991 A1 PL 354991A1 PL 00354991 A PL00354991 A PL 00354991A PL 35499100 A PL35499100 A PL 35499100A PL 354991 A1 PL354991 A1 PL 354991A1
Authority
PL
Poland
Prior art keywords
diphenylpropionate
dimethoxyphenyl
yloxy
pyrimidin
ethoxy
Prior art date
Application number
PL00354991A
Other languages
English (en)
Polish (pl)
Inventor
Rolf Jansen
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of PL354991A1 publication Critical patent/PL354991A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL00354991A 1999-10-26 2000-10-17 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist PL354991A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19951617A DE19951617A1 (de) 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
PL354991A1 true PL354991A1 (en) 2004-03-22

Family

ID=7926968

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354991A PL354991A1 (en) 1999-10-26 2000-10-17 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist

Country Status (7)

Country Link
EP (1) EP1223960A2 (xx)
JP (1) JP2004500343A (xx)
CN (1) CN1384753A (xx)
CA (1) CA2388614A1 (xx)
DE (1) DE19951617A1 (xx)
PL (1) PL354991A1 (xx)
WO (1) WO2001030372A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0816053B2 (ja) * 1986-12-04 1996-02-21 大正製薬株式会社 貼付剤の製造方法
JPH0436237A (ja) * 1990-06-01 1992-02-06 Taiho Yakuhin Kogyo Kk 抗腫瘍性複合製剤
WO1993010767A1 (de) * 1991-12-05 1993-06-10 Alfatec-Pharma Gmbh Perorale applikationsform für peptidarzneistoffe, insbesondere insulin
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
JP4189044B2 (ja) * 1997-07-01 2008-12-03 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Also Published As

Publication number Publication date
CN1384753A (zh) 2002-12-11
EP1223960A2 (de) 2002-07-24
WO2001030372A2 (de) 2001-05-03
DE19951617A1 (de) 2001-05-03
JP2004500343A (ja) 2004-01-08
CA2388614A1 (en) 2001-05-03
WO2001030372A3 (de) 2001-11-01

Similar Documents

Publication Publication Date Title
IL141034A0 (en) Uracil compounds and use thereof
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
PL351312A1 (en) New compounds, their preparation and use
IL154948A0 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
IS6248A (is) Pýrimidín-2, 4, 6-tríón málmpróteinasa latar
ATE229795T1 (de) Hautverträgliche handreiniger, insbesondere grobhandreiniger
GB0021885D0 (en) New use
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
ITTO20000503A0 (it) Macchina per caffe'.
HUP0102615A3 (en) 2-(2-chlorophenyl)-3,4-dihydro-2h-pyrrol derivatives
EP1210084A4 (en) PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
GB0026467D0 (en) Compound, composition and use
PL354991A1 (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
IL149312A0 (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
AU5569200A (en) Uracil compounds and use thereof
GB0005301D0 (en) Compound, composition and use
AU2002224825A1 (en) Substituted amidoalkyl uracils and the use thereof
AU2457400A (en) Brush holder, use of the brush holder, brush and brush set
ZA200109120B (en) Use of Arylalkanoylpyridazines.
GB0006864D0 (en) New use
ZA200301162B (en) Gem-substituted alpha V beta 3 integrin antagonists.
GB0021668D0 (en) New use
GB9929772D0 (en) New use
GB0004183D0 (en) New use